Cyclacel Pharmaceuticals Preferred Stock Widgets and Gadgets
| CYCCP Preferred Stock | USD 5.80 0.04 0.69% |
| Intraday Equity Chart Quick Equity Feed Equity Search Quote Ticker Widgets Data Sheet |
Live Stock Ticker Example
- CYCCP Cyclacel Pharmaceuticals
- CYCCP 5.8 0.04
- Low 5.25
- High 5.82
- Alpha -0.33
- Beta -0.46
- Return On Equity -0.6
- Return On Asset -0.42
- Current Valuation 24.42 M
- Shares Outstanding 12.5 M
- Shares Owned By Insiders 0.47 %
- Price To Earning (2.62) X
- Gross Profit (338 K)
- EBITDA (15 M)
- Net Income (18.89 M)
- Cash And Equivalents 29.08 M
- Cash Per Share 2.32 X
- Total Debt 113 K
- Debt To Equity 0 %
- Current Ratio 6.38 X
- Book Value Per Share 1.76 X
- Cash Flow From Operations (18.54 M)
- Earnings Per Share (2.05) X
- Number Of Employees 14
- Beta 1.16
- Market Capitalization 23.14 M
- Total Asset 42.59 M
- Annual Yield 0.04 %
- Five Year Return 9.20 %
- Net Asset 42.59 M
- Accumulation Distribution 0.0979
- Daily Balance Of Power 0.0702
- Rate Of Daily Change 1.01
- Day Median Price 5.54
- Day Typical Price 5.62
- Market Facilitation Index 0.57
- Price Action Indicator 0.28
- Period Momentum Indicator 0.04
Market Snapshot Widget Example
DAX Index Germany | 20,406 0.1 | |
Taiwan Weighted Taiwan | 23,020 0.11 | |
PSI 20 Stock Portugal | 6,354 0.11 | |
CROBEX Croatia | 3,194 0.13 | |
Budapest SE Hungary | 80,166 0.46 | |
IDX 30 Jakarta Indonesia | 443.33 1.05 | |
ISEQ 20 Price Ireland | 1,648 0.0006 | |
NYSE Comp USA | 19,729 0.2 | |
Tel Aviv 35 Israel | 2,335 0.04 | |
Coreshares Index Tracker South Afric | 1,098 1.29 | |
IPC MEXICO Mexico | 51,653 0.06 | |
KL Technology Malaysia | 63.70 2.18 | |
IBEX 35 Index Spain | 11,752 0.11 | |
SP Merval Argentina | 1,000,000 0.00 | |
Austrian Traded Index Austria | 3,648 0.28 | |
SPASX Dividend Opportunities Australia | 1,680 0.49 | |
HNX 30 Vietnam | 480.47 0.88 | |
Bucharest BET-NG Romania | 1,247 0.38 | |
AMS Small Cap Netherlands | 1,240 0.14 | |
Oslo Exchange Mutual Norway | 1,405 0.14 | |
BEL Small Belgium | 8,042 0.12 | |
Basic Materials Brazil | 5,772 2.08 | |
Swiss Leader Price Switzerland | 1,938 0.22 | |
Fondo Mutuo ETF Chile | 1,408 0.51 | |
Athens General Comp Greece | 1,469 0.36 | |
Stock Exchange Of Thailand | 1,432 0.57 | |
PX Prague Stock Czech Repub | 1,749 0.60 | |
THE PHILIPPINE STOCK Philippines | 6,617 0.37 | |
WIG 30 Poland | 2,896 0.14 | |
BIST Electricity Turkey | 514.73 0.73 |
Investing Ideas
In addition to having Cyclacel Pharmaceuticals in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.Thematic Opportunities
Explore Investment Opportunities
Compare Cyclacel Pharmaceuticals
Compare Cyclacel Pharmaceuticals To Peers
Additional Tools for Cyclacel Preferred Stock Analysis
When running Cyclacel Pharmaceuticals' price analysis, check to measure Cyclacel Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Cyclacel Pharmaceuticals is operating at the current time. Most of Cyclacel Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Cyclacel Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Cyclacel Pharmaceuticals' price. Additionally, you may evaluate how the addition of Cyclacel Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.